vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and E.W. SCRIPPS Co (SSP). Click either name above to swap in a different company.

E.W. SCRIPPS Co is the larger business by last-quarter revenue ($560.3M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). E.W. SCRIPPS Co runs the higher net margin — -5.1% vs -10.1%, a 5.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -23.1%). E.W. SCRIPPS Co produced more free cash flow last quarter ($31.2M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -0.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

The E. W. Scripps Company, also known as Scripps, is an American broadcasting company founded in 1878 as a chain of daily newspapers by Edward Willis "E. W." Scripps and his sister, Ellen Browning Scripps. It was also formerly a media conglomerate. The company is headquartered at the Scripps Center in Cincinnati, Ohio. Its corporate motto is "Give light and the people will find their own way", which is symbolized by the media empire's longtime lighthouse logo.

CLOV vs SSP — Head-to-Head

Bigger by revenue
SSP
SSP
1.1× larger
SSP
$560.3M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+67.8% gap
CLOV
44.7%
-23.1%
SSP
Higher net margin
SSP
SSP
5.0% more per $
SSP
-5.1%
-10.1%
CLOV
More free cash flow
SSP
SSP
$100.2M more FCF
SSP
$31.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-0.1%
SSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
SSP
SSP
Revenue
$487.7M
$560.3M
Net Profit
$-49.3M
$-28.5M
Gross Margin
Operating Margin
-10.1%
7.5%
Net Margin
-10.1%
-5.1%
Revenue YoY
44.7%
-23.1%
Net Profit YoY
-123.2%
-129.9%
EPS (diluted)
$-0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
SSP
SSP
Q4 25
$487.7M
$560.3M
Q3 25
$496.6M
$525.9M
Q2 25
$477.6M
$540.1M
Q1 25
$462.3M
$524.4M
Q4 24
$337.0M
$728.4M
Q3 24
$331.0M
$646.3M
Q2 24
$356.3M
$573.6M
Q1 24
$346.9M
$561.5M
Net Profit
CLOV
CLOV
SSP
SSP
Q4 25
$-49.3M
$-28.5M
Q3 25
$-24.4M
$-33.0M
Q2 25
$-10.6M
$-36.0M
Q1 25
$-1.3M
$-3.5M
Q4 24
$-22.1M
$95.4M
Q3 24
$-9.2M
$47.8M
Q2 24
$7.4M
$1.4M
Q1 24
$-19.2M
$1.6M
Gross Margin
CLOV
CLOV
SSP
SSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
SSP
SSP
Q4 25
-10.1%
7.5%
Q3 25
-4.9%
7.2%
Q2 25
-2.2%
14.2%
Q1 25
-0.3%
5.2%
Q4 24
-6.4%
26.3%
Q3 24
-2.7%
18.8%
Q2 24
2.0%
9.7%
Q1 24
-6.5%
7.7%
Net Margin
CLOV
CLOV
SSP
SSP
Q4 25
-10.1%
-5.1%
Q3 25
-4.9%
-6.3%
Q2 25
-2.2%
-6.7%
Q1 25
-0.3%
-0.7%
Q4 24
-6.6%
13.1%
Q3 24
-2.8%
7.4%
Q2 24
2.1%
0.2%
Q1 24
-5.5%
0.3%
EPS (diluted)
CLOV
CLOV
SSP
SSP
Q4 25
$-0.51
Q3 25
$-0.55
Q2 25
$-0.59
Q1 25
$-0.22
Q4 24
$0.94
Q3 24
$0.37
Q2 24
$-0.15
Q1 24
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
SSP
SSP
Cash + ST InvestmentsLiquidity on hand
$78.3M
$27.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.2B
Total Assets
$541.0M
$5.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
SSP
SSP
Q4 25
$78.3M
$27.9M
Q3 25
$54.7M
Q2 25
$31.7M
Q1 25
$24.0M
Q4 24
$194.5M
$23.9M
Q3 24
$288.0M
$34.6M
Q2 24
$254.8M
$26.7M
Q1 24
$208.3M
$30.2M
Total Debt
CLOV
CLOV
SSP
SSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$2.6B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
SSP
SSP
Q4 25
$308.7M
$1.2B
Q3 25
$340.9M
$1.3B
Q2 25
$344.2M
$1.3B
Q1 25
$336.1M
$1.3B
Q4 24
$341.1M
$1.3B
Q3 24
$342.2M
$1.2B
Q2 24
$324.9M
$1.2B
Q1 24
$292.5M
$1.2B
Total Assets
CLOV
CLOV
SSP
SSP
Q4 25
$541.0M
$5.0B
Q3 25
$559.7M
$5.1B
Q2 25
$575.0M
$5.1B
Q1 25
$583.7M
$5.1B
Q4 24
$580.7M
$5.2B
Q3 24
$653.0M
$5.3B
Q2 24
$674.2M
$5.3B
Q1 24
$671.8M
$5.3B
Debt / Equity
CLOV
CLOV
SSP
SSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.98×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
SSP
SSP
Operating Cash FlowLast quarter
$-66.9M
$45.1M
Free Cash FlowOCF − Capex
$-69.0M
$31.2M
FCF MarginFCF / Revenue
-14.1%
5.6%
Capex IntensityCapex / Revenue
0.4%
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
SSP
SSP
Q4 25
$-66.9M
$45.1M
Q3 25
$12.1M
$21.8M
Q2 25
$5.4M
$-10.5M
Q1 25
$-16.3M
$-3.3M
Q4 24
$34.8M
$153.3M
Q3 24
$50.0M
$140.6M
Q2 24
$44.8M
$26.4M
Q1 24
$25.9M
$45.4M
Free Cash Flow
CLOV
CLOV
SSP
SSP
Q4 25
$-69.0M
$31.2M
Q3 25
$11.4M
$6.4M
Q2 25
$4.8M
$-22.7M
Q1 25
$-16.5M
$-8.4M
Q4 24
$33.3M
$146.9M
Q3 24
$49.6M
$127.4M
Q2 24
$44.4M
$2.8M
Q1 24
$25.5M
$23.3M
FCF Margin
CLOV
CLOV
SSP
SSP
Q4 25
-14.1%
5.6%
Q3 25
2.3%
1.2%
Q2 25
1.0%
-4.2%
Q1 25
-3.6%
-1.6%
Q4 24
9.9%
20.2%
Q3 24
15.0%
19.7%
Q2 24
12.5%
0.5%
Q1 24
7.3%
4.1%
Capex Intensity
CLOV
CLOV
SSP
SSP
Q4 25
0.4%
2.5%
Q3 25
0.1%
2.9%
Q2 25
0.1%
2.3%
Q1 25
0.0%
1.0%
Q4 24
0.5%
0.9%
Q3 24
0.1%
2.0%
Q2 24
0.1%
4.1%
Q1 24
0.1%
3.9%
Cash Conversion
CLOV
CLOV
SSP
SSP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.61×
Q3 24
2.94×
Q2 24
6.04×
18.45×
Q1 24
27.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

SSP
SSP

Local Media Segment$355.1M63%
Scripps Networks$199.5M36%
Political Advertising Revenue$10.0M2%

Related Comparisons